Abstract: A vehicle lamp includes a long solid-core shaped light guide; a first light source that irradiates an end portion of the long solid-core shaped light guide in a longitudinal direction such that light is radiated long from an end side of the vehicle lamp toward another end side of the vehicle lamp; and a second light source that irradiates the another end side of the vehicle lamp to a lateral outer side.

Abstract: A vehicle lamp is formed using a light guide body. Thus light with an excellent aesthetic quality can be emitted without increasing the number of components. The structure has a light guide part (6a) formed on a light guide member (6). The light guide part (6a) emits light in an elongated shape by irradiating a first light-emitting diode (9) provided on one end of the light guide part (6a) in the longitudinal direction. A projecting part (6g) projects reward on the rear face of the light guide part (6a), which is the light-emitting face. A light emission suppressing part (6h) is provided on the projection end face of the projecting part (6g) and has a metal film (6f) formed by vapor deposition.

Abstract: A door mirror has a turn lamp that can be mounted easily and without an increased size. The turn lamp (2) has a housing (3) and an outer lens (4) that are formed by molding. A light emitting diode (6) is mounted in the housing (3), and the outer lens (4) covers the housing (3). The housing (3) and the outer lens (4) are integrated by a joint (7) produced by injection molding and placed at a butt section at which the housing (3) and the outer lens (4) are butted together. Steps (7c, 7d) are formed at the butt section integrated by the joint (7) of the turn lamp (2), and a lower end edge section (1c) and a left end edge section (1e) that form an opening (1b) of a body (1) of the door mirror (DM) are butted to the steps (7c, 7d).

Abstract: A method for promoting expression of a heat shock protein, or for inhibiting cell injury or cell death, or for treating a disease for which cell or tissue protection is desired, or for promoting production of IL-10, or for inhibiting production of IL-8, by administering an effective amount of a fraction containing a hyaluronic acid tetrasaccharide comprising four saccharide residues and having certain physicochemical properties or by administering an effective amount of an isolated and substantially pure tetrasaccharide of formula (1) described in the application. Methods for preserving an organ.

Abstract: A vehicle lamp is formed using a light guide body. Thus light with an excellent aesthetic quality can be emitted without increasing the number of components. The structure has a light guide part (6a) formed on a light guide member (6). The light guide part (6a) emits light in an elongated shape by irradiating a first light-emitting diode (9) provided on one end of the light guide part (6a) in the longitudinal direction. A projecting part (6g) projects reward on the rear face of the light guide part (6a), which is the light-emitting face. A light emission suppressing part (6h) is provided on the projection end face of the projecting part (6g) and has a metal film (6f) formed by vapor deposition.

Abstract: A method for promoting expression of a heat shock protein, or for inhibiting cell injury or cell death, or for treating a disease for which cell or tissue protection is desired, or for promoting production of IL-10, or for inhibiting production of IL-8, by administering an effective amount of a fraction containing a hyaluronic acid tetrasaccharide comprising four saccharide residues and having certain physicochemical properties or by administering an effective amount of an isolated and substantially pure tetrasaccharide of formula (1) described in the application. Methods for preserving an organ.

Abstract: A door mirror has a turn lamp that can be mounted easily and without an increased size. The turn lamp (2) has a housing (3) and an outer lens (4) that are formed by molding. A light emitting diode (6) is mounted in the housing (3), and the outer lens (4) covers the housing (3). The housing (3) and the outer lens (4) are integrated by a joint (7) produced by injection molding and placed at a butt section at which the housing (3) and the outer lens (4) are butted together. Steps (7c, 7d) are formed at the butt section integrated by the joint (7) of the turn lamp (2), and a lower end edge section (1c) and a left end edge section (1e) that form an opening (1b) of a body (1) of the door mirror (DM) are butted to the steps (7c, 7d).

Abstract: A turn lamp includes a base housing; a light source unit incorporated with a light source and housed in the base housing; an inner housing provided with a long and solid light guide; a lens cover that covers the base housing; and a diffused reflection generator that is structured such that light from the light source leaks out long from the light guide.

Abstract: A vehicle lamp includes a long solid-core shaped light guide; a first light source that irradiates an end portion of the long solid-core shaped light guide in a longitudinal direction such that light is radiated long from an end side of the vehicle lamp toward another end side of the vehicle lamp; and a second light source that irradiates the another end side of the vehicle lamp to a lateral outer side.

Abstract: A method for promoting expression of a heat shock protein, or for inhibiting cell injury or cell death, or for treating a disease for which cell or tissue protection is desired, or for promoting production of IL-10, or for inhibiting production of IL-8, by administering an effective amount of a fraction containing a hyaluronic acid tetrasaccharide comprising four saccharide residues and having certain physicochemical properties or by administering an effective amount of an isolated and substantially pure tetrasaccharide of formula (1) described in the application. Methods for preserving an organ.

Abstract: A method for promoting expression of a heat shock protein, or for inhibiting cell injury or cell death, or for treating a disease for which cell or tissue protection is desired, or for promoting production of IL-10, or for inhibiting production of IL-8, by administering an effective amount of a fraction containing a hyaluronic acid tetrasaccharide comprising four saccharide residues and having certain physicochemical properties or by administering an effective amount of an isolated and substantially pure tetrasaccharide of formula (1) described in the application. Methods for preserving an organ.

Abstract: Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical properties, and drugs containing the same. The hyaluronic acid oligosaccharides of the present invention are extremely useful, because they exert superior pharmaceutical effects as active ingredients of a heat shock protein expression promoter, cell death inhibitor, cell injury inhibitor and cell and tissue protecting agent (e.g., organ preservation agent, antiulcer agent, antihepatopathic agent, IL-10 production promoter or IL-8 production inhibitor) and exhibit high safety.

Abstract: Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical properties, and drugs containing the same. The hyaluronic acid oligosaccharides of the present invention are extremely useful, because they exert superior pharmaceutical effects as active ingredients of a heat shock protein expression promoter, cell death inhibitor, cell injury inhibitor and cell and tissue protecting agent (e.g., organ preservation agent, antiulcer agent, antihepatopathic agent, IL-10 production promoter or IL-8 production inhibitor) and exhibit high safety.

Abstract: A turn lamp includes a base housing; a light source unit incorporated with a light source and housed in the base housing; an inner housing provided with a long and solid light guide; a lens cover that covers the base housing; and a diffused reflection generator that is structured such that light from the light source leaks out long from the light guide.

Abstract: A method for promoting expression of a heat shock protein, or for inhibiting cell injury or cell death, or for treating a disease for which cell or tissue protection is desired, or for promoting production of IL-10, or for inhibiting production of IL-8, by administering an effective amount of a fraction containing a hyaluronic acid tetrasaccharide comprising four saccharide residues and having certain physicochemical properties or by administering an effective amount of an isolated and substantially pure tetrasaccharide of formula (1) described in the application. Methods for preserving an organ.

Abstract: To provide a process for producing an aluminum oxide powder, whereby the content of impurities is controlled by a physical means. A process for producing an aluminum oxide powder, which comprises pulverizing electrofused alumina by a batch system and classifying the obtained pulverized product to obtain an aluminum oxide powder different in the content of impurities. It is possible to obtain aluminum oxide of high purity by pulverization to a smaller average particle size and separating a powder having a larger average particle size by classification.

Abstract: To provide a process for producing an aluminum oxide powder, whereby the content of impurities is controlled by a physical means. A process for producing an aluminum oxide powder, which comprises pulverizing electrofused alumina by a batch system and classifying the obtained pulverized product to obtain an aluminum oxide powder different in the content of impurities. It is possible to obtain aluminum oxide of high purity by pulverization to a smaller average particle size and separating a powder having a larger average particle size by classification.

Abstract: Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical properties, and drugs containing the same. The hyaluronic acid oligosaccharides of the present invention are extremely useful, because they exert superior pharmaceutical effects as active ingredients of a heat shock protein expression promoter, cell death inhibitor, cell injury inhibitor and cell and tissue protecting agent (e.g., organ preservation agent, antiulcer agent, antihepatopathic agent, IL-10 production promoter or IL-8 production inhibitor) and exhibit high safety.

Abstract: An object of the present invention is to provide an IL-12 expression controlling agent, an inhibitor of IL-12 expression and an enhancer of IL-12 expression for oral administration, which comprise hyaluronan as an active ingredient. The present invention relates to an interleukin-12 expression controlling agent, which comprises hyaluronan as an active ingredient. Specifically, it is an inhibitor of interleukin-12 expression, which comprises hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 600,000 to 3,000,000 as an active ingredient, or an enhancer of interleukin-12 expression for oral administration, which comprise hyaluronan or the pharmaceutically acceptable salt thereof having a weight average molecular weight of from 50,000 to 400,000 as an active ingredient.

Abstract: An IL-12 production inhibitor which comprises, as an active ingredient, a keratan sulfate oligosaccharide or a derivative thereof, for example, a keratan sulfate oligosaccharide comprising at least one repeating unit of either one of the disaccharides represented by the following formulas: Gal (6s)-GlcNAc (6s) and Gal (6s)-GlcNAc wherein Gal represents a galactose residue, GlcNAc represents an N-acetylglucosamine residue, 6s indicates that 6-0-sulfate ester is formed at a Hydroxyl group at the 6-position, and - represents a glycosidic linkage.